N-(4-OXO-4-(3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-(1,2,4)TRIAZOLO(4,3-A)PYRAZIN-7(8H)-YL)-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-YL)FORMAMIDE, (R)-
UNII WB4LTV7ZF5
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-(1,2,4)triazolo(4,3-a)pyrazin-7(8h)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)formamide, (r)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WB4LTV7ZF5.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C17H15F6N5O2 FUSZMDYZGVENHU-SNVBAGLBSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-(1,2,4)triazolo(4,3-a)pyrazin-7(8h)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)formamide, (r)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.